GM2 Gangliosidoses
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Synergistic Enteral Regimen for Treatment of the Gangliosidoses (NCT02030015) | University of Minnesota | 2015-12-22 |
| Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral Doses (NCT00672022) | Children's National Research Institute | 2004-07-01 |
Track GM2 Gangliosidoses automatically
Every clearance here is in the API, with alerts when new ones post.